Brucellosis Vaccines Market
Overview:
Brucellosis occurs due to infections resulting from a bacteria in animals. This disease can transmit into humans if they are in close contact with animals that are infected by the virus. Brucellosis vaccines are used in animals for prevention of brucellosis disease. B. abortus S19 is the most common vaccines used in cattle for prevention of the disease and this is the reference vaccine used for comparing other vaccines with.
Click Here for Free Sample Copy (Use corporate email ID Get Higher Priority) @ https://www.coherentmarketinsights.com/insight/request-sample/5038
Market Drivers:
Rise in initiatives taken by government such as introduction of vaccinations programs is anticipated to boost growth of the global brucellosis vaccines market over the forecast period. For instance, the Nagaland department of Animal Husbandry and Veterinary Services, India announced the launch of a program of brucellosis vaccination in the state in January 2022. As the increasing prevalence of the disease in animals could lead to higher risk of disease transmission into people handling animals as well as veterinarians.
Moreover, rise in number of brucellosis cases is also expected to boost growth of the global brucellosis vaccines market over the forecast period. For instance, as per the National Center for Biotechnology Information published article in 2018, brucellosis affected 23.6% of crossbreed cattle and 13.8% of indigenous cattle in Nyagatare District, Rwanda.
For More Information or Query or Customization before Buying, Visit at – https://www.coherentmarketinsights.com/insight/talk-to-analyst/5038
Impact of COVID-19:
The epidemic of COVID-19 significantly impacted the market for brucellosis vaccines, as many countries imposed lockdown regulations after the virus outbreak to control the further virus spread. During this period, several vet clinics and services were closed down and visits to veterinarians for the purpose of vaccination declined during the pandemic. Moreover, there was decline in dairy products and meat consumption during the pandemic which disrupted the livestock expansion all over the world.
Key Takeaways:
- The global brucellosis vaccines market is estimated to show a CAGR of 4.7% during the forecast period. This is due to growing brucellosis cases across the globe. For instance, as per the data of National Center for Biotechnology Information, the brucellosis prevalence in herds having cows without any abortion history was observed to be 38.5% and in animals with abortion history it was 17.0%, in Nyagatare, Rwanda.
- The RB51 Vaccine segment among Type is anticipated to witness substantial growth in the global brucellosis during the forecast period, as RB51 is commonly utilized for protecting cattle against abortion and infection as the approved B. abortus vaccine.
Key Players:
Major players active in the global brucellosis vaccines market are VETAL Animal Health Products Inc., Merck & Co., Fivet Animal Health, CZ Vaccines, Laboratorios Tornel, Colorado Serum Company, Jordan Bio-industries Center, Indian Immunologicals Ltd., Veterinary Technologies Corporation, and Hester Biosciences Limited
Avail 40% Discount on various license types on Immediate Purchase @ https://www.coherentmarketinsights.com/promo/buynow/5038
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Market Trends
- Key Developments
- Product Launch
- Regulatory Guidelines
- Acquisitions, Collaborations, & Partnerships
- Epidemiology
- PEST Analysis
- Global Brucellosis Vaccines Market – Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- Supply and Demand Analysis
- Global Brucellosis Vaccines Market, By Type, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018–2030
- Segment Trends
- RB51 Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- S19 Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- B19 Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Others (45/20 vaccine, SR82 vaccine, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Introduction
- Global Brucellosis Vaccines Market, By Application, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018–2030
- Segment Trends
- Cattle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Sheep
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Goat
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Others (swine, horses, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/brucellosis-vaccines-market-4316
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837